Previous Article | Next Article 
Journal of Virology, December 2002, p. 12097-12111, Vol. 76, No. 23
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.23.12097-12111.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Toward Testing the Hypothesis that Group B Coxsackieviruses (CVB) Trigger Insulin-Dependent Diabetes: Inoculating Nonobese Diabetic Mice with CVB Markedly Lowers Diabetes Incidence
S. Tracy,1* K. M. Drescher,2 N. M. Chapman,1 K.-S. Kim,1 S. D. Carson,1 S. Pirruccello,3 P. H. Lane,4 J. R. Romero,4 and J. S. Leser1
Enterovirus Research Laboratory,1
Department of Pathology and Microbiology,3
Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska 68198,4
Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska 681782
Received 16 May 2002/
Accepted 21 August 2002
Insulin-dependent (type 1) diabetes mellitus (T1D) onset is mediated by individual human genetics as well as undefined environmental influences such as viral infections. The group B coxsackieviruses (CVB) are commonly named as putative T1D-inducing agents. We studied CVB replication in nonobese diabetic (NOD) mice to assess how infection by diverse CVB strains affected T1D incidence in a model of human T1D. Inoculation of 4- or 8-week-old NOD mice with any of nine different CVB strains significantly reduced the incidence of T1D by 2- to 10-fold over a 10-month period relative to T1D incidences in mock-infected control mice. Greater protection was conferred by more-pathogenic CVB strains relative to less-virulent or avirulent strains. Two CVB3 strains were employed to further explore the relationship of CVB virulence phenotypes to T1D onset and incidence: a pathogenic strain (CVB3/M) and a nonvirulent strain (CVB3/GA). CVB3/M replicated to four- to fivefold-higher titers than CVB3/GA in the pancreas and induced widespread pancreatitis, whereas CVB3/GA induced no pancreatitis. Apoptotic nuclei were detected by TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling) assay in CVB3/M-infected pancreata but not in CVB3/GA-infected pancreata. In situ hybridization detected CVB3 RNA in acinar tissue but not in pancreatic islets. Although islets demonstrated inflammatory infiltrates in CVB3-protected mice, insulin remained detectable by immunohistochemistry in these islets but not in those from diabetic mice. Enzyme-linked immunosorbent assay-based examination of murine sera for immunoglobulin G1 (IgG1) and IgG2a immunoreactivity against diabetic autoantigens insulin and HSP60 revealed no statistically significant relationship between CVB3-protected mice or diabetic mice and specific autoimmunity. However, when pooled sera from CVB3/M-protected mice were used to probe a Western blot of pancreatic proteins, numerous proteins were detected, whereas only one band was detected by sera from CVB3/GA-protected mice. No proteins were detected by sera from diabetic or normal mice. Cumulatively, these data do not support the hypothesis that CVB are causative agents of T1D. To the contrary, CVB infections provide significant protection from T1D onset in NOD mice. Possible mechanisms by which this virus-induced protection may occur are discussed.
* Corresponding author. Mailing address: Enterovirus Research Laboratory, Department of Pathology and Microbiology, University of Nebraska Medical Center, 986495 Nebraska Medical Center, Omaha, NE 68198-6495. Phone: (402) 559-7747. Fax: (402) 559-4077. E-mail:
stracy{at}unmc.edu.
Journal of Virology, December 2002, p. 12097-12111, Vol. 76, No. 23
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.23.12097-12111.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Filippi, C. M., von Herrath, M. G.
(2008). Viral Trigger for Type 1 Diabetes: Pros and Cons. Diabetes
57: 2863-2871
[Full Text]
-
Graham, K. L., Sanders, N., Tan, Y., Allison, J., Kay, T. W. H., Coulson, B. S.
(2008). Rotavirus Infection Accelerates Type 1 Diabetes in Mice with Established Insulitis. J. Virol.
82: 6139-6149
[Abstract]
[Full Text]
-
Kim, K.-S., Chapman, N. M., Tracy, S.
(2008). Replication of Coxsackievirus B3 in Primary Cell Cultures Generates Novel Viral Genome Deletions. J. Virol.
82: 2033-2037
[Abstract]
[Full Text]
-
Smith, K. A., Efstathiou, S., Cooke, A.
(2007). Murine Gammaherpesvirus-68 Infection Alters Self-Antigen Presentation and Type 1 Diabetes Onset in NOD Mice. J. Immunol.
179: 7325-7333
[Abstract]
[Full Text]
-
Carson, S. D., Kim, K.-S., Pirruccello, S. J., Tracy, S., Chapman, N. M.
(2007). Endogenous low-level expression of the coxsackievirus and adenovirus receptor enables coxsackievirus B3 infection of RD cells. J. Gen. Virol.
88: 3031-3038
[Abstract]
[Full Text]
-
Graham, K. L., O'Donnell, J. A., Tan, Y., Sanders, N., Carrington, E. M., Allison, J., Coulson, B. S.
(2007). Rotavirus Infection of Infant and Young Adult Nonobese Diabetic Mice Involves Extraintestinal Spread and Delays Diabetes Onset. J. Virol.
81: 6446-6458
[Abstract]
[Full Text]
-
Bailey, J. M., Tapprich, W. E.
(2007). Structure of the 5' Nontranslated Region of the Coxsackievirus B3 Genome: Chemical Modification and Comparative Sequence Analysis. J. Virol.
81: 650-668
[Abstract]
[Full Text]
-
Gay, R. T., Belisle, S., Beck, M. A., Meydani, S. N.
(2006). An aged host promotes the evolution of avirulent coxsackievirus into a virulent strain. Proc. Natl. Acad. Sci. USA
103: 13825-13830
[Abstract]
[Full Text]
-
Kanno, T., Kim, K., Kono, K., Drescher, K. M., Chapman, N. M., Tracy, S.
(2006). Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.. J. Virol.
80: 5637-5643
[Abstract]
[Full Text]
-
Wetzel, J. D., Barton, E. S., Chappell, J. D., Baer, G. S., Mochow-Grundy, M., Rodgers, S. E., Shyr, Y., Powers, A. C., Thomas, J. W., Dermody, T. S.
(2006). Reovirus Delays Diabetes Onset but Does Not Prevent Insulitis in Nonobese Diabetic Mice. J. Virol.
80: 3078-3082
[Abstract]
[Full Text]
-
Bopegamage, S., Kovacova, J., Vargova, A., Motusova, J., Petrovicova, A., Benkovicova, M., Gomolcak, P., Bakkers, J., van Kuppeveld, F., Melchers, W. J. G., Galama, J. M.
(2005). Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection. J. Gen. Virol.
86: 3271-3280
[Abstract]
[Full Text]
-
Christen, U., von Herrath, M. G.
(2005). Infections and Autoimmunity--Good or Bad?. J. Immunol.
174: 7481-7486
[Abstract]
[Full Text]
-
Kim, K.-S., Tracy, S., Tapprich, W., Bailey, J., Lee, C.-K., Kim, K., Barry, W. H., Chapman, N. M.
(2005). 5'-Terminal Deletions Occur in Coxsackievirus B3 during Replication in Murine Hearts and Cardiac Myocyte Cultures and Correlate with Encapsidation of Negative-Strand Viral RNA. J. Virol.
79: 7024-7041
[Abstract]
[Full Text]
-
Serreze, D. V., Wasserfall, C., Ottendorfer, E. W., Stalvey, M., Pierce, M. A., Gauntt, C., O'Donnell, B., Flanagan, J. B., Campbell-Thompson, M., Ellis, T. M., Atkinson, M. A.
(2005). Diabetes Acceleration or Prevention by a Coxsackievirus B4 Infection: Critical Requirements for both Interleukin-4 and Gamma Interferon. J. Virol.
79: 1045-1052
[Abstract]
[Full Text]
-
Lee, C.-K., Kono, K., Haas, E., Kim, K.-S., Drescher, K. M., Chapman, N. M., Tracy, S.
(2005). Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate. J. Gen. Virol.
86: 197-210
[Abstract]
[Full Text]
-
Flodstrom, M., Tsai, D., Fine, C., Maday, A., Sarvetnick, N.
(2003). Diabetogenic Potential of Human Pathogens Uncovered in Experimentally Permissive {beta}-Cells. Diabetes
52: 2025-2034
[Abstract]
[Full Text]